Product availability at Ankleshwar will commence from fourth quarter of 2021, informed Bharat Biotech.
Further, Bharat Biotech claimed that it has already deployed multiple production lines at its Hyderabad and Bengaluru campuses.
Adding Chiron Behring to its line up, the company said, it effectively takes the volumes up to 1 billion doses per annum.
India witnessed a rise of 2,76,110 fresh coronavirus cases on Thursday, taking the totally tally to 25,772,440. India also reported 3,874 new deaths, taking the toll to 2,87,122.
(The Quint is available on Telegram. For handpicked stories every day, subscribe to us on Telegram)
>Crime Today News | INDIA